Perrigo Ordinary Shares reported 338.1M in Selling and Administration Expenses for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Selling And Administration Expenses Change
Abbott ABT:US $ 2.74B 44M
Abbvie ABBV:US $ 3.13B 73M
Bayer BAYN:GR 4.47B 527M
Bristol Myers Squibb BMY:US $ 1.78B 46M
Catalent CTLT:US $ 226M 19M
Coherus Biosciences CHRS:US $ 51.28M 2.52M
Corcept Therapeutics CORT:US $ 37.81M 264K
Dr.Reddys Laboratories DRRD:IN 23.8B 38M
Eli Lilly And LLY:US $ 1.63B 67.2M
Endo International Ordinary Shares ENDP:US 180.83M 45.18M
Horizon Pharma HZNP:US 398.22M 25.49M
JAZZ PHA JAZZ:US 325.67M 16.86M
Johnson & Johnson JNJ:US $ 6.23B 288M
Lannett LCI:US $ 25.76M 8.18M
Merk MRK:US $ 2.42B 118M
Pacira Pharmaceuticals PCRX:US $ 65M 743K
Perrigo Ordinary Shares PRGO:US 338.1M 55.8M
Pfizer PFE:US $ 3.2B 506M
Phibro Animal Health PAHC:US $ 55.54M 3.11M
Prestige Brands PBH:US $ 66.66M 1.92M
Supernus Pharmaceuticals SUPN:US $ 100.48M 10.02M
Teva Pharmaceutical TEVA:IT 849M 30M
Xeris Pharmaceuticals Inc XERS:US $ 32.98M 5.67M
Zoetis ZTS:US $ 529M 64M